Tanner Johanns

Medicine & Life Sciences

1. Glioblastoma 100%
2. T-Lymphocytes 57%
3. Immunotherapy 46%
4. Brain Neoplasms 35%
5. Neoplasms 33%
6. Glioma 32%
7. Melanoma 27%
8. Listeria monocytogenes 27%
9. Salmonella Infections 22%
10. Therapeutics 19%
11. Mutation 18%
12. Brain 17%
13. Immunity 17%
14. Radiotherapy 16%
15. Temozolomide 16%
16. Isocitrate Dehydrogenase 16%
17. Survival 14%
18. Progression-Free Survival 13%
19. interleukin-21 13%
20. Vaccines 13%
21. pembrolizumab 12%
22. Infections 12%
23. Salmonella 11%
24. Vaccination 11%
25. Doxorubicin 11%
26. talimogene laherparepvec 10%
27. Listeriosis 10%
28. Neoplasm Metastasis 10%
29. T-Cell Antigen Receptor 9%
30. Lasers 9%
31. Salvage Therapy 9%
32. dabrafenib 9%
33. trametinib 9%
34. Hot Temperature 9%
35. Neoplasm Antigens 9%
36. Ligands 9%
37. Peptides 8%
38. Interleukin-17 8%
39. Tadalafil 8%
40. CTLA-4 Antigen 8%
41. Lymphoscintigraphy 8%
42. Enzyme-Linked Immunospot Assay 8%
43. Combined Vaccines 8%
44. Tumor Cell Line 8%
45. Astrocytoma 7%
46. Radiation 7%
47. Oligodendroglioma 7%
48. Adenosine Triphosphatases 7%
49. Mitogen-Activated Protein Kinase Kinases 7%
50. Chemoradiotherapy 7%